Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking

Cell Death and Differentiation

Volumn 22, Issue 1, 2015, Pages 96-107

  Martin Antonio, B ^a,b   Najjar, A ^a   Robinson, S N ^a   Chew, C ^a   Li, S ^a   Yvon, E ^a   Thomas, M W ^a   Mc Niece, I ^a   Orlowski, R ^a   Munoz Pinedo C ^c   Bueno, C ^b   Menendez, P ^b,d   Fernandez De Larrea C ^b   Urbano Ispizua, A ^b   Shpall, E J ^a   Shah, N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GRANZYME B; LIPID; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; REACTIVE OXYGEN METABOLITE; CASP3 PROTEIN, HUMAN; GRANZYME; GZMB PROTEIN, HUMAN; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NCR3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL DEATH; CELL MIGRATION; CELL THERAPY; CELL TRANSFER; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LYSOSOME; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TARGET CELL; UMBILICAL CORD BLOOD; CELLULAR IMMUNITY; FEMALE; FETUS BLOOD; IMMUNOLOGY; K562 CELL LINE; MALE; PATHOLOGY; SECRETORY VESICLE;

MURINAE;

CASPASE 3; FEMALE; FETAL BLOOD; GRANZYMES; HUMANS; IMMUNITY, CELLULAR; K562 CELLS; KILLER CELLS, NATURAL; MALE; MULTIPLE MYELOMA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; REACTIVE OXYGEN SPECIES; SECRETORY VESICLES;

EID: 84924991737     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.120     Document Type: Article

References (38)

1. Bertaina A, Locatelli F, Moretta L. Transplantation and innate immunity: the lesson of natural killer cells. Ital J Pediatr 2009; 35: 44.
2. Masilamani M, Peruzzi G, Borrego F, Coligan JE. Endocytosis and intracellular trafficking of human natural killer cell receptors. Traffic 2009; 10: 1735-1744.
3. Lugini L, Cecchetti S, Huber V, Luciani F, Macchia G, Spadaro F et al. Immune surveillance properties of human NK cell-derived exosomes. J Immunol 2012; 189: 2833-2842.
4. Ewen CL, Kane KP, Bleackley RC. A quarter century of granzymes. Cell Death Differ 2012; 19: 28-35.
5. Okada S, Li Q, Whitin JC, Clayberger C, Krensky AM. Intracellular mediators of granulysininduced cell death. J Immunol 2003; 171: 2556-2562.
6. Aporta A, Catalán E, Galán-Malo P, Ramírez-Labrada A, Pérez M, Azaceta G et al. Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors. Biochem Pharmacol 2014; 87: 410-423.
7. Saini RV, Wilson C, Finn MW, Wang T, Krensky AM, Clayberger C. Granulysin delivered by cytotoxic cells damages endoplasmic reticulum and activates caspase-7 in target cells. J Immunol 2011; 186: 3497-3504.
8. Zhang H, Zhong C, Shi L, Guo Y, Fan Z. Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to necroptosis. J Immunol 2009; 182: 6993-7000.
9. Smith D, Yong K. Multiple myeloma. BMJ 2013; 346: f3863.
10. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011; 364: 1046-1060.
11. Aronson LI, Davies FE. DangER: protein ovERload. Targeting protein degradation to treat myeloma. Haematologica 2012; 97: 1119-1130.
12. Sonneveld P, Goldschmidt H, Rosiñol L, Bladé J, Lahuerta JJ, Cavo M et al. Bortezomibbased versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials. J Clin Oncol 2013; 31: 3279-3287.
13. Mimura N, Fulciniti M, Gorgun G, Tai YT, Cirstea D, Santo L et al. Blockade of XBP1 splicing by inhibition of IRE1alpha is a promising therapeutic option in multiple myeloma. Blood 2012; 119: 5772-5781.
14. Tagoug I, Jordheim LP, Herveau S, Matera EL, Huber AL, Chettab K et al. Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors. Clin Cancer Res 2013; 19: 3556-3566.
15. Wu WK, Wu YC, Yu L, Li ZJ, Sung JJ, Cho CH. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem Biophys Res Commun 2008; 374: 258-263.
16. Wang XJ, Yu J,Wong SH, Cheng AS, Chan FK, Ng SS et al. A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy. Autophagy 2013; 9: 1500-1508.
17. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368: 1845-1846.
18. Carroll RG, Martin SJ. Autophagy in multiple myeloma: what makes you stronger can also kill you. Cancer Cell 2013; 23: 425-426.
19. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 2009; 69: 4415-4423.
20. Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJN et al. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. PLoS One 2013; 8: e76781.
21. Swift BE, Williams BA, Kosaka Y, Wang XH, Medin JA, Viswanathan S et al. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. Haematologica 2012; 97: 1020-1028.
22. Durymanov MO, Beletkaia EA, Ulasov AV, Khramtsov YV, Trusov GA, Rodichenko NS et al. Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1. J Control Release 2012; 163: 211-219.
23. Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol 2004; 5: 121-132.
24. Peruzzi G, Masilamani M, Borrego F, Coligan JE. Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A. Immunol Res 2009; 43: 210-222.
25. Wayteck L. Effects of endocytosis inhibitors on transfection mediated by polyplexes and lipoplexes carrying mRNA. Master thesis, Ghent University, Ghent, Belgium, 2010.
26. Koh CH, Cheung NS. Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell Signal 2006; 18: 1844-1853.
27. Liu D, Martina JA, Wu XS, Hammer JA 3rd, Long EO. Two modes of lytic granule fusion during degranulation by natural killer cells. Immunol Cell Biol 2011; 89: 728-738.
28. Martín-Antonio B, Carmona M, Falantes J, Gil E, Baez A, Suarez M et al. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. Haematologica 2011; 96: 102-109.
29. Aits S, Jäättelä M. Lysosomal cell death at a glance. J Cell Sci. 2013; 126(Pt 9): 1905-1912.
30. Bröker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005; 11: 3155-3162.
31. Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci 2013; 14: 5338-5366.
32. Saka HA, Valdivia R. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu Rev Cell Dev Biol 2012; 28: 411-437.
33. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005; 438: 612-621.
34. Carnero A. MAP17, a ROS-dependent oncogene. Front Oncol 2012; 2: 112.
35. Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 2013; 9: 1292-1307.
36. Lamy L, Ngo VN, Emre NC, Shaffer AL 3rd, Yang Y, Tian E et al. Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell 2013; 23: 435-449.
37. Appelqvist H, Wäster P, Kagedal K, Öllinger K. The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol 2013; 5: 214-226.
38. Huang CC, Chen KL, Cheung CH, Chang JY. Autophagy induced by cathepsin S inhibition induces early ROS production, oxidative DNA damage, and cell death via xanthine oxidase. Free Radic Biol Med 2013; 65: 1473-1486.